Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting Read more about Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting
Zai Lab Statement on SEC Listing Matter - TC Read more about Zai Lab Statement on SEC Listing Matter - TC
Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022 - TC Read more about Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022 - TC
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting - TC Read more about Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting - TC
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer-TCC Read more about Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer-TCC
Zai Lab Statement on SEC Provisional Listing Matter - TC Read more about Zai Lab Statement on SEC Provisional Listing Matter - TC
Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021 - TC Read more about Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021 - TC
Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China - TC Read more about Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China - TC
Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2022 - TC Read more about Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2022 - TC
Zai Lab Announces Upcoming Presentation at February Investor Conference - TC Read more about Zai Lab Announces Upcoming Presentation at February Investor Conference - TC